Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05490277 · ClinicalTrials.gov registry record · NA

Vibrotactile Coordinated Reset for the Treatment of Chronic Stroke

A NA study, sponsored by Stanford University.

Not yet
Registry status
NA
Development phase
20
Enrollment target

NCT05490277: Clinical Trial NA study, sponsored by Stanford University.

NCT05490277 is a NA study that has not yet begun recruiting, run by Stanford University. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05490277, a NA study, has not yet begun recruiting, sponsored by Stanford University.

NOT YET RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target

Study Summary

The purpose of our study is to evaluate Vibrotactile Coordinated Reset stimulation (vCR) and its effects on motor ability within stroke patients. vCR will be administered with a device called the Vibrotactile (VT) Brain Glove. vCR is expected to provide patients with a non-invasive therapy to aid in recovery from a stroke. This study will include a dedicated sham arm that will aid in understanding true treatment effects from vCR.

Interventions

  • DEVICE Sham vibrotactile coordinated reset
  • DEVICE Active Vibrotactile coordinated reset

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2026-01-15
Est. Completion 2028-11-15
Phase NA

Sponsor

Stanford University

1,744 total trials

What the Registry Record Tells You About NCT05490277

The ClinicalTrials.gov registry entry for NCT05490277 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Sham vibrotactile coordinated reset is the first listed.

NCT05490277 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05490277 about?

NCT05490277 is a clinical study titled "Vibrotactile Coordinated Reset for the Treatment of Chronic Stroke". The purpose of our study is to evaluate Vibrotactile Coordinated Reset stimulation (vCR) and its effects on motor ability within stroke patients. vCR will be administered with a device called the Vibrotactile (VT) Brain Glove. vCR is expected to provide patients with a non-invasive therapy to aid in...

What is the current status of trial NCT05490277?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2026-01-15. Estimated completion is 2028-11-15.

What interventions are being tested in trial NCT05490277?

The interventions under investigation include: Sham vibrotactile coordinated reset (DEVICE), Active Vibrotactile coordinated reset (DEVICE).

Who is sponsoring clinical trial NCT05490277?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.